Broker Forecast - Exane BNP Paribas issues a broker note on Smith & Nephew PLC

Writer, Stock Market Wire
Friday, February 8, 2019 - 10:40

Exane BNP Paribas today downgrades its investment rating on Smith & Nephew PLC (LON:SN.) to neutral (from outperform) and raised its price target to 1525p (from 1475p).

Broker Forecasts data provided by www.sharesmagazine.co.uk


Related content

Smith & Nephew to complete new surgical robots platform by end 2019

Medical technology group Smith & Nephew said its next generation surgical robots platform was planned for completion in late 2019.

A full commercial release was...

Wed, 13/03/2019 - 07:34


Smith & Nephew acquires Osiris Therapeutics for around $660m

Medical technology company Smith & Nephew said it had agreed to acquire regenerative medicine group Osiris Therapeutics for around $660m.

Osiris Therapeutics offered products including...

Tue, 12/03/2019 - 13:07


Broker Forecast - Goldman Sachs issues a broker note on Smith & Nephew PLC

Goldman Sachs today reaffirms its neutral investment rating on Smith & Nephew PLC (LON:SN.) and raised its price target to 1440p (from 1400p).

Broker Forecasts...

Mon, 11/02/2019 - 15:40


Broker Forecast - JP Morgan Cazenove issues a broker note on Smith & Nephew PLC

JP Morgan Cazenove today reaffirms its neutral investment rating on Smith & Nephew PLC (LON:SN.) and raised its price target to 1516p (from 1477p).

Broker...

Mon, 11/02/2019 - 14:50


Broker Forecast - Credit Suisse issues a broker note on Smith & Nephew PLC

Credit Suisse today reaffirms its neutral investment rating on Smith & Nephew PLC (LON:SN.) and raised its price target to 1390p (from 1330p).

Broker Forecasts...

Fri, 08/02/2019 - 10:50